Omega Flex, Inc. — Form 10-Q Summary
Business Context and Reporting Period
Omega Flex manufactures flexible metal hose and piping for residential and commercial construction, industrial, petrochemical, pharmaceutical, transportation, and other applications. Products are manufactured primarily in Exton, Pennsylvania, with limited U.K. manufacturing, and sold through distributors, wholesalers, sales representatives, and OEMs.
This report covers the three and six months ended June 30, 2013. The financial statements are unaudited and prepared under U.S. GAAP. The company operates as one reportable segment.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2013 | Three Months Ended June 30, 2012 | Six Months Ended June 30, 2013 | Six Months Ended June 30, 2012 |
|---|---|---|---|---|
| Net sales | $18.892 million | $14.256 million | $35.274 million | $28.804 million |
| Gross profit | $10.221 million | $7.087 million | $18.821 million | $14.542 million |
| Gross margin | 54.1% | 49.7% | 53.4% | 50.5% |
| Operating profit | $3.894 million | $0.735 million | $6.357 million | $6.733 million |
| Operating margin | 20.6% | 5.2% | 18.0% | 23.4% |
| Net income attributable to Omega Flex | $2.535 million | $0.477 million | $4.117 million | $4.397 million |
| Basic and diluted EPS | $0.25 | $0.05 | $0.41 | $0.44 |
Second-quarter sales increased 32.5%, driven primarily by higher unit volume, recovering residential construction activity, broader acceptance of newer products, and modest pricing increases. Six-month sales increased 22.5%.
Six-month operating profit declined 5.6% because the prior-year period included a $4.7 million insurance legal recovery. Excluding that recovery and related auxiliary costs, management stated that first-half operating profit increased 127.5% year over year.
Cash Flow, Liquidity, Debt, and Balance Sheet
- Cash and cash equivalents were $2.502 million at June 30, 2013, compared with $0.939 million at December 31, 2012.
- Six-month cash provided by operating activities was $2.342 million, compared with $4.642 million in the prior-year period. The comparison was affected by the $4.7 million insurance recovery in 2012 and a $1.3 million U.K. litigation settlement payment in 2013.
- Capital expenditures were $0.405 million, compared with $0.105 million in the prior-year period. Management indicated that total 2013 capital spending could approach $1.8 million for manufacturing-capacity and facility expansion.
- The company repaid the $0.324 million outstanding balance on its revolving credit facility and had no borrowings at June 30, 2013. The facility provides up to $10 million, matures December 31, 2014, and was subject to a stated borrowing rate of 2.02% based on the company’s financial ratios. The company was in compliance with all debt covenants.
- Total assets were $33.608 million and total liabilities were $9.792 million at June 30, 2013. Shareholders’ equity, including noncontrolling interest, was $23.816 million.
- Management stated that existing cash and cash equivalents should be sufficient to meet anticipated needs for at least the next 12 months.
Material Changes Versus the Prior Comparable Period
- Gross margin expanded to 54.1% in the second quarter and 53.4% for the first six months, from 49.7% and 50.5%, respectively, due to pricing and cost-of-sales efficiencies.
- Selling expenses increased modestly in absolute dollars but declined as a percentage of sales to 16.9% for the quarter and 17.7% for the six months.
- General and administrative expense declined year over year, while incentive compensation increased in connection with stronger quarterly profitability.
- Engineering expense increased to $1.344 million for the first six months from $1.230 million.
- Accrued compensation increased to $1.352 million from $0.349 million at year-end, primarily due to current-year incentive compensation accruals. Accrued commissions and sales incentives declined to $2.375 million from $3.671 million following payment of 2012 programs.
- The company paid the previously accrued approximately $1.3 million U.K. settlement in March 2013; no related liability remained at June 30, 2013.
Guidance, Outlook, Risks, and Unusual Items
- Management expects continued capital spending related to expanded manufacturing and warehousing capacity; total 2013 capital expenditures could approach $1.8 million.
- Management cited residential construction recovery, product acceptance, volume growth, modest pricing, and manufacturing efficiencies as contributors to performance.
- Product-liability claims have increased in frequency. The company estimates aggregate maximum exposure for current open claims at approximately $3.340 million within applicable insurance deductibles or retentions, but cannot estimate ultimate liability. Recorded product-liability-related liabilities were $0.638 million at June 30, 2013.
- The company won a 2013 Missouri product-liability trial. A separate Pennsylvania strict-liability matter remains on appeal before the Pennsylvania Supreme Court.
- Approximately $0.269 million related to prepaid insurance premiums involved in an external-party fraud remains in a governmental custodial account. Recovery and related costs are uncertain.
- The prior-year $4.7 million insurance legal recovery was nonrecurring and materially affects year-over-year six-month comparisons.
- Other risks identified by management include weather, regulatory changes, customer preferences, economic conditions, competition, litigation, environmental matters, foreign-currency effects, and estimates for revenue incentives, receivables, inventory, goodwill, product-liability reserves, and income taxes.
- No material subsequent events were reported through the filing date. Management concluded that disclosure controls and procedures were effective and reported no material change in internal control over financial reporting.
Important Facts for Investors to Verify
- Whether sales growth and elevated gross margins are sustained as residential construction and newer-product adoption develop.
- The normalized earnings trend excluding the $4.7 million 2012 insurance recovery and related costs.
- The ultimate cost and timing of pending product-liability claims, including the Pennsylvania appeal and the stated approximately $3.340 million aggregate exposure.
- The recovery status of the $0.269 million insurance-fraud-related custodial assets.
- The timing and funding of planned 2013 capital expenditures, potentially approaching $1.8 million.
- Working-capital cash requirements, particularly accrued compensation, commissions, sales incentives, and customer receivables.
- Foreign-currency effects from the U.K. subsidiary and the company’s ability to maintain liquidity without drawing on its credit facility.